Clinical IQ, LLC, Florham Park, New Jersey.
CriticalPoint, LLC, Florham Park, New Jersey.
Int J Pharm Compd. 2024 Jan-Feb;28(1):44-55.
Compounders worldwide are responsible for ensuring that the sterile preparations they dispense are pure, potent, and safe. To achieve that result, proper cleaning and disinfection of International Organization for Standardization controlled environments must occur. Because those tasks must be performed according to established standards, the compounding pharmacist must research regulatory requirements and appropriate products for use. In this report, we focus on U.S. regulations, guiding entities, and effective products that enable compliance with the increasingly stringent procedures required for pharmaceutical compounding. We also review cleaning and disinfecting processes, discuss the importance of correctly choosing and using disinfectants and/ or sporicidal disinfectants with surface claims in the cleanroom, and provide answers to questions frequently asked by staff who use those agents. In addition, we profile specific disinfectants that are compliant with United States Pharmacopeia Chapter <797> and current good manufacturing practice standards. Biological safety cabinets and compounding aseptic containment isolators must undergo an additional process that deactivates hazardous drug residues and removes them from the interior surfaces of those devices before they are cleaned and disinfected, but that discussion is beyond the scope of this article.
全球的药剂师负责确保他们配制的无菌制剂是纯净、有效且安全的。为了实现这一目标,必须对 ISO 控制环境进行适当的清洁和消毒。由于这些任务必须按照既定标准执行,因此药剂师必须研究监管要求和适用产品。在本报告中,我们重点介绍美国的法规、指导实体和有效产品,以符合制药配制所需的日益严格的程序。我们还审查了清洁和消毒过程,讨论了在洁净室中正确选择和使用消毒剂和/或具有表面声称的杀菌消毒剂的重要性,并回答了经常使用这些制剂的员工提出的问题。此外,我们还介绍了符合美国药典第 <797> 章和现行良好生产规范标准的特定消毒剂。生物安全柜和无菌配制隔离器必须进行额外的处理,以在清洁和消毒之前使危险药物残留失活并从这些设备的内部表面去除,但该讨论超出了本文的范围。